Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1996-05-06
1997-12-16
Prior, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514182, A61K 3157
Patent
active
056985452
ABSTRACT:
Angiostatic steroids for use in controlling ocular hypertension are disclosed. Pharmaceutical compositions of the angiostatic steroids and methods for their use in treating ocular hypertension, including controlling the ocular hypertension associated with primary open angle glaucoma, are disclosed. In addition, the combination of the compounds with glucocorticoids for the prevention of elevated IOP during the treatment of inflammation is disclosed.
REFERENCES:
patent: 4617299 (1986-10-01), Knepper
patent: 4812448 (1989-03-01), Knepper
patent: 4863912 (1989-09-01), Southren et al.
patent: 5371078 (1994-12-01), Clark et al.
Crum, et al., Science, vol. 230, pp. 1375-1378 (Dec. 1985), "A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment".
Ingber, et al., Endocrinology, vol. 119, pp. 1768-1775 (1986), "A Possible Mechanism for Inhibition of Angiogenesis by Angiostatic Steroids" Induction of Capillary Basement Membrane Dissolution.
Southern, et al., Investigative Ophthalmology and Visual Science, vol. 28, pp. 901-903 (May 1987), "Intraocular Hypotensive Effect of a Topically Applied Cortisol Metabolite: 3-alpha-5, beta-tetrahydrocortisol".
Folkman, et al., Ann. Surg., vol. 206(3):, pp. 374-382, (1987), "Angiostatic Steroids".
Rohen, Johanness W., Ophthalmology, vol. 90(7), pp. 758-764, (1983), "Why is Intraocular Pressure Elevated in Chronic Simple Glaucoma?".
Knepper, et al., Pediatric Neuroscience, vol. 12, pp. 240-251, (1985/86), "Glycosaminoglycans and Outflow Pathways of the Eye and Brain".
Clark Abbot F.
Conrow Raymond E.
Alcon Laboratories Inc.
Prior Kimberly J.
Yeager Sally
LandOfFree
Angiostatic steroids and methods and compositions for controllin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatic steroids and methods and compositions for controllin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatic steroids and methods and compositions for controllin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206252